KCPG
ISEE

Kavar Capital Partners Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Kavar Capital Partners Group’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,500
Closed -$5K – 483
2019
Q2 		$5K Buy
+3,500
New +$4.8K ﹤0.01% 433
2018
Q3 		– Sell
-3,500
Closed -$10K – 412
2018
Q2 		$10K Hold
3,500
– – 0.01% 318
2018
Q1 		$10K Buy
+3,500
New +$10.1K 0.01% 321

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Kavar Capital Partners Group's ISEE Position: Q3 2019 in Review

Kavar Capital Partners Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2019, closing a stake of 3,500 shares — an estimated $5K sold.

Kavar Capital Partners Group first reported a position in ISEE in Q1 2018 and held it in 3 quarters. The position peaked at $10K in Q2 2018. 48 funds tracked by Wall St. Rank hold ISEE as of Q3 2019.

  • Kavar Capital Partners Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Kavar Capital Partners Group sold 3,500 IVERIC bio, Inc. Common Stock shares in Q3 2019, an estimated $5K.
  • Kavar Capital Partners Group first reported a position in IVERIC bio, Inc. Common Stock in Q1 2018 and held it in 3 quarters.
  • Kavar Capital Partners Group's IVERIC bio, Inc. Common Stock position peaked at $10K in Q2 2018.
  • 48 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2019.

Based on Kavar Capital Partners Group's 13F filing for Q3 2019, filed 12 Nov 2019.